Polaryx Therapeutics, Inc. (PLYX) stock
PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.60−0.07 (-4.19%)
Close on Nov 17, 2026Market cap $79.75MP/E –Yield –
Polaryx Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for Polaryx Therapeutics
Polaryx Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?